U.S. stocks finished higher Tuesday, October 27, 2026, with the Nasdaq Composite rising 1.18%, the Russell 2000 advancing 1.16%, and the S&P 500 gaining 0.60%. The Dow Jones Industrial Average edged up just 0.03%, underscoring the gap between technology-led momentum and the blue-chip benchmark. Renewed interest in artificial intelligence, an unexpectedly strong rebound in consumer confidence, and a busy corporate earnings calendar shaped the session. Many widely also prepared for Wednesday’s Federal Reserve decision and earnings reports from Alphabet (GOOG, GOOGL) and Microsoft (MSFT).

Stock Market Closing Performance: October 27, 2026

Treasury Yields, Volatility, Gold, Oil and Bitcoin

The combination of stronger equities and a lower VIX was consistent with improved risk appetite. However, the Treasury reading showed that Tuesday’s stock-market advance did not depend on falling long-term yields. Small-cap participation also gave the rally a broader dimension than technology strength alone. These are interpretations of the supplied cross-market figures, rather than proof of a single market catalyst.

Why Stocks Rose: AI Enthusiasm Returns Ahead of Major Earnings

Artificial intelligence remained central to Tuesday’s trading narrative. Semiconductor strength helped lift technology shares as many reassessed both the growth opportunity and the financing demands behind the AI infrastructure expansion. Enthusiasm surrounding Anthropic’s public IPO filing provided another focal point for the sector. Nvidia (NVDA) announced plans to invest $3 billion in Meta Platforms (META), alongside expanded collaboration involving Meta Platforms’ (META) Muse AI models. The investment forms part of a much larger infrastructure-funding effort, highlighting how closely chip suppliers and their largest customers are becoming financially connected. The implications run in two directions. Supplier investment can support additional infrastructure spending, but equity financing also raises questions about shareholder dilution and the eventual returns on that investment. Tuesday’s advance reflected renewed enthusiasm for AI growth, not a resolution of those underlying concerns.

Alphabet Earnings: Cloud Growth Meets Search Competition

Alphabet (GOOG, GOOGL) is scheduled to report third-quarter results after Wednesday’s closing bell. Analyst expectations cited in the earnings preview call for earnings of $3.01 per share on revenue of $127.8 billion, with cloud revenue projected at $28.9 billion. These figures are forecasts, not reported result. Many will be watching whether cloud demand and sales of custom AI processors can expand the company’s earnings opportunities while its search business faces competition from AI agents. Oracle (ORCL) announced plans to deploy Alphabet’s (GOOG, GOOGL) Tensor Processing Units in its own infrastructure, adding another commercial channel for the technology.

Microsoft Earnings: Azure Demand and Spending Discipline

Microsoft (MSFT) is also scheduled to report Wednesday after the close, with its fiscal first-quarter release expected to offer an important check on enterprise AI demand. The earnings preview cited analyst expectations of $4.27 per share in earnings and $90.6 billion in revenue. The central issue is the relationship between growth and investment. Forecast capital expenditures, including leases, of approximately $45.9 billion put Azure expansion, AI adoption and cash-generation capacity at the center of the report. Strong demand would support the investment case, but investors still need evidence that infrastructure spending can translate into durable profitability.

Macroeconomic Report: Consumer Confidence Rebounds, Housing Remains Subdued

Consumer Confidence Beats Expectations

The Conference Board’s consumer confidence index rose to 91.7 in October from an upwardly revised 84.2 in September. Economists surveyed by Reuters reported that analysts had expected a reading of 81, making the improvement substantially stronger than anticipated. Easing gasoline prices helped explain the rebound, although respondents continued to express frustration with food costs, living expenses and energy prices. The distinction matters: improving confidence suggests households feel less pessimistic, but it does not mean purchasing-power pressures have disappeared. For the market, the report offered support for the view that consumer demand can remain resilient. It also complicated any simple argument that weaker household sentiment would necessarily push the Federal Reserve toward easier policy. That is an economic interpretation of the stronger survey result, not a forecast of Wednesday’s decision.

New-Home Sales Point to a Softer Housing Backdrop

September new-home sales were reported at a seasonally adjusted annual rate of 676,000, compared with a revised 680,000 in August. That represented a 0.6% monthly decline and a 5.3% decrease from a year earlier. The result illustrated the unevenness of the economic picture. Consumer confidence improved, but housing activity remained below its year-earlier pace. A modest monthly change should not be treated as evidence of a decisive housing-market turn.

Federal Reserve Decision Arrives Wednesday

The Federal Reserve’s scheduled October 27–28 policy meeting concludes Wednesday, with the decision scheduled for 2 p.m. Eastern time. Market coverage entering the meeting described expectations for unchanged rates, with attention focused on whether policymakers would maintain a restrictive message about inflation. An unchanged policy rate would therefore not necessarily amount to a more supportive stance for stocks. With the supplied 10-year Treasury yield near 5%, the policy backdrop remains an important counterweight to earnings optimism. Tuesday’s rally showed many folks’ willingness to take risk ahead of the announcement, rather than certainty about its outcome.

Corporate Earnings Show a Resilient but Uneven Consumer

Tuesday’s earnings reports offered a more nuanced picture than a uniformly strong consumer economy.

• Coca-Cola (KO) reported adjusted earnings of $0.91 per share and revenue of $13.4 billion, exceeding the expectations cited in market coverage. Global unit case volume increased 5%, although North American volume was flat.
• United Parcel Service (UPS) raised its full-year revenue outlook to approximately $92.6 billion from $91.2 billion, supported by management’s assessment of resilient consumers and a strong holiday-demand outlook.
• Royal Caribbean Group (RCL) reported 9% growth in guests served, reaching 2.7 million during the quarter, while bookings for 2027 were running ahead of historical level.
• Whirlpool (WHR) missed earnings and revenue expectations and reduced its full-year revenue forecast, with North American sales falling more than 8%.

The common thread is selectivity. Spending on travel, recognizable brands and certain services remained durable, while housing-linked purchases and other categories showed pressure. Revenue growth also needs to be separated from volume growth when price increases account for part of the improvement.

Coca-Cola’s Brand Momentum Provides a Useful Example

Coca-Cola (KO) reported double-digit North American volume growth for Diet Coke and Coca-Cola Zero, even as overall regional volume remained flat. Management’s discussion of Diet Coke’s popularity illustrated how individual products can outperform a slower broader market. For many, that distinction helps explain why strong brand execution can coexist with evidence of a financially stretched consumer

Nuclear Power Connects the AI Trade to Energy Infrastructure

Constellation Energy (CEG) emerged as another AI-related focal point after the U.S. government offered up to $5 billion in conditional financing to modernize and upgrade nuclear facilities. The projects are expected to add nearly 1.1 gigawatts of electricity capacity. The conditional nature of the commitment matters. It is not equivalent to an unconditional cash payment or completed construction. The broader investment significance lies in expanding output from existing reactors as electricity demand grows, including demand associated with data centers. The announcement reinforced the connection between AI infrastructure and power generation. The investment story extends beyond processors and software to the electricity supply needed to operate the systems.

Robinhood Earnings: Options and Event Contracts Offset Crypto Weakness

Robinhood Markets (HOOD) reported a 12% increase in third-quarter revenue. Transaction-based revenue rose 19% to $867 million, supported by options and event contracts, while cryptocurrency revenue declined sharply. Options revenue increased 31% to $399 million, equities revenue rose 41% to $121 million, and cryptocurrency revenue fell 55% to $120 million. Quarterly net deposits totaled $15.7 billion. The results highlighted a shifting business mix. Robinhood Markets (HOOD) is developing additional revenue streams, but the durability of transaction growth remains an important question when activity varies substantially across products.

What Many Will Watch Next

Wednesday brings two closely connected tests for the market:

1. Federal Reserve policy and communication, including how policymakers balance inflation concerns against signs of economic resilience.
2. Results from Alphabet (GOOG, GOOGL) and Microsoft (MSFT), particularly cloud growth, AI monetization, infrastructure spending and the relationship between investment and future cash generation.

Today’s VP Watchlist Corporate Updates

Amwell® (NYSE: AMWL)

Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $13.59, +.37%.

AMWL announced (Sept 8) announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA’s digital health infrastructure. The VA anticipates the Amwell platform will support a broad range of clinical services, enhance care coordination, and improve access for our Veterans across the VA enterprise. The Letter of Intent follows a comprehensive evaluation process by the VA, in which it determined that Amwell’s virtual health platform aligns with the Department’s strategic objectives to expand access to high-quality, secure, and reliable virtual care services for Veterans nationwide through the VA’s current electronic health record modernization efforts. Specifically, the capabilities Amwell demonstrated in scalable video consultations, interoperability, cybersecurity compliance, and support for integrated care delivery were significant factors in this determination.

Amwell® has received Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell’s ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

The Company also reiterated recently its objective to achieve positive cash flow from operations in the fourth quarter of 2026.

Serina Therapeutics (NYSE: SER)

Serina Theraeuptics (NYSE: SER, $1.67) is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ PlatformTM provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology.

On Thursday, September 24, 2026, Serina CEO Steve Ledger discussed discuss Serina’s programs’ progress during Tribe Public’s “A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress”webinar, followed by a live Q&A. You may view it below.

SER announced (Sept. 9) that the independent Safety Monitoring Committee (SMC) has completed its blinded review of Cohort 1 of the ongoing Phase 1b registrational study of SER-252 in patients with advanced Parkinson’s disease and recommended that the study advance to Cohort 2. Cohort 1 evaluated the lowest dose level in the single-ascending-dose portion of the study. In addition to supporting continued dose escalation, blinded Cohort 1 observations showed a pharmacokinetic profile consistent with the sustained apomorphine exposure SER-252 is designed to provide and included sustained periods of improvement in motor function in individual patients on exploratory clinical measures.

Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Inc. (EPRX, $7.08, +3.36%), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (Oct. 15) that the ongoing RESOLVE study evaluating the safety and efficacy of EP-104GI for the treatment of Eosinophilic Esophagitis (“EoE”) has reached its enrollment target. “This is a significant milestone for the RESOLVE trial and the development of EP-104GI as a potential treatment option in EoE” said Dr. James Helliwell, Chief Executive Officer of Eupraxia. “We look forward to our interim analysis in December where we will be reporting on symptoms, histologic findings and safety in the first 60 patients in Phase 2b to reach 6 months. Data will also be available on the patients at 3, 9- and 12-month timepoints giving a fulsome interim look at the RESOLVE Trial”.

Modular Medical, Inc. (NASDAQ: MODD)

Modular Medical, Inc. (NASDAQ: MODD, $1.65), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, announced (October 15) the launch of two innovative digital education resources designed to assist people living with diabetes build familiarity and confidence with insulin therapy ahead of formal training on the Pivot insulin delivery system. Developed in partnership with Relevate Health Games, the new tools use game-based technology to walk patients through the skills needed for insulin pump therapy. The resources are designed to help reduce barriers to adoption by allowing prospective users to become familiar with pump therapy before beginning formal onboarding. The first educational module gives users a virtual, hands-on walkthrough of the Pivot insulin delivery system. In approximately 15 minutes, users can visualize how to unpack the system, prepare and apply the pump, and understand the basic operational functions. The Pivot module was first previewed at the ADCES 2025 Annual Conference in August 2025. Healthcare providers may also use the platform to gauge a patient’s interest in pump therapy and ability to navigate basic operational tasks associated with insulin delivery devices. The experience offers clinicians valuable insight into patient engagement, learning readiness, and willingness to transition from multiple daily injections to a more advanced insulin delivery approach.

MODD announced (September 4) that it has secured a contract with a national U.S. pharmacy benefit manager (PBM) in the United States. Pursuant to the contract, the Company’s Pivot insulin delivery system is now available through the national PBM. The Company believes the engagement with this national PBM represents a significant step forward in broadening patient access to the Company’s Pivot tubeless patch pump and will further validate the Pivot pump as an accessible therapeutic option for people living with diabetes.

MODD announced (September 3) that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the system’s functionality and providing users with greater flexibility and customization options in bolus dosing, an enhanced user-interface (UI), and other software upgrades.

MODD CEO, Jeb Besser, co-hosted a Tribe Public’s CEO Presentation and Q&A Webinar Event titled “The Road To Revenue: Modular Medical’s Strategy For Launching Pivot,” that was held Friday, September 4, 2026.. You may watch the event video below now if you missed it below now.

Doximity, Inc. (NYSE: DOCS)

Doximity (NYSE: DOCS, $33.24, +.48%) is the leading digital platform for U.S. medical professionals. The company’s network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

Doximity and Wolters Kluwer Health, announced (Oct. 20) that UpToDate’s trusted, evidence-based, clinical content will be accessible directly within Doximity’s fast-growing AI clinical decision support tool, Ask.

DOCS announced (Oct. 13) it has extended its 13-year partnership with U.S. News & World Report, the nation’s most trusted source of independent healthcare information, rankings and guidance to help patients identify the best care for their needs.

Nvidia (NVDA, $217.94, +.90%)

NVIDIA Corp. (NASDAQ: NVDA), at its GTC event in Berlin recently, the company unveiled its DSX POD, a reference design for an AI data center packed into a box about the size of a standard shipping container. According to Nvidia, the Vera Rubin-powered DSX PODs will arrive on site, ready to be plugged into the power, cooling, and networking infrastructure, reducing deployment time from six months to 14 days. The company said DSX PODs won’t replace traditional data centers, but will serve as a means to start running AI applications before brick-and-mortar facilities are ready.

The Sources

1. Stock Market Live Updates: Futures, AI Stocks and the Federal Reserve Outlook
2. Stock Market Today: Dow, S&P 500 and Nasdaq Rise as Semiconductor Stocks Lead Technology Higher
3. Alphabet Third-Quarter Earnings Preview: AI Growth and Competitive Risks
4. Microsoft Fiscal First-Quarter Earnings Preview: Azure Growth in Focus
5. U.S. Offers Constellation Up to $5 Billion in Financing to Support Nuclear Power
6. Coca-Cola CEO Discusses Diet Coke’s Popularity and Consumer Trends
7. Early Third-Quarter Earnings Show a Resilient U.S. Consumer, With Signs of Strain
8. Robinhood Third-Quarter Earnings: Options and Event Contracts Offset Cryptocurrency Weakness
9. Reuters: U.S. Consumer Confidence Improves in October
10. Federal Reserve: FOMC Meeting Calendars and Information
11. Federal Reserve: October 2026 Calendar
12. September U.S. New-Home Sales: 676,000 Annualized Versus 650,000 Expected